TrialPanorama/TrialPanorama-database huggingface dataset:
Study 39046783 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study 39046783 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39046783 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 39046783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 39047180 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 39047219 — Predictive Biomarker (PRD): Hormone receptor
Study 39047288 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 39048547 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 39048549 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39048549 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 39048549 — Predictive Biomarker (PRD): ELANE mRNA
Genes: ELANE; ELA2
Study 39048549 — Predictive Biomarker (PRD): DEFA4 mRNA
Genes: DEFA4; DEF4
Study 39048549 — Predictive Biomarker (PRD): OLFM4 mRNA
Genes: OLFM4; GW112; UNQ362/PRO698
Study 39049042 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 39049073 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 39049073 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39049092 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 39049121 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 39049803 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study 39049803 — Predictive Biomarker (PRD): RRM2 mRNA
Genes: RRM2; RR2
Study 39049828 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39050403 — Surrogate Endpoint (SUR): Blood pressure
Study 39050802 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 39050802 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 39052241 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 39052242 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39052330 — Surrogate Endpoint (SUR): Blood pressure
Study 39052718 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 39052726 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39053010 — Monitoring Biomarker (MOI): Cell-free DNA
Study 39053611 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 39053611 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 39053948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39053954 — Surrogate Endpoint (SUR): Serum uric acid
Study 39053957 — Predictive Biomarker (PRD): SLC25A3 mRNA
Genes: SLC25A3; PHC; OK/SW-cl.48
Study 39054420 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 39054460 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 39054462 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 39054476 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 39054479 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39054485 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 39054485 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 39054491 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 39054765 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 39054765 — Safety Biomarker (SAF): BDNF
Study 39055379 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 39055495 — Predictive Biomarker (PRD): Hormone receptor
Study 39055703 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39055703 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39055703 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 39056160 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39056338 — Predictive Biomarker (PRD): RXFP1 mRNA
Genes: RXFP1; LGR7
Study 39058972 — Surrogate Endpoint (SUR): Serum creatinine
Study 39059184 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 39059184 — Predictive Biomarker (PRD): Hormone receptor
Study 39059389 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39059398 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 39059398 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 39059405 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 39059405 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study 39059407 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study 39059887 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39060022 — Safety Biomarker (SAF): Interleukin 12
Study 39060374 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study 39060905 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39060905 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39061094 — Predictive Biomarker (PRD): ZNF335 mRNA
Genes: ZNF335
Study 39061599 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 39062003 — Predictive Biomarker (PRD): SLC12A2 mRNA
Genes: SLC12A2; NKCC1
Study 39065260 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39066962 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39066978 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 39067465 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 39067464 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 39067513 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39067618 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 39068298 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 39068298 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 39068385 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 39068739 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 39068739 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study 39068945 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 39069466 — Predictive Biomarker (PRD): NFAT5 mRNA
Genes: NFAT5; KIAA0827; TONEBP
Study 39069614 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 39069898 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39069898 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39069917 — Surrogate Endpoint (SUR): Blood pressure
Study 39070742 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 39072232 — Monitoring Biomarker (MOI): Cell-free DNA
Study 39072240 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 39072240 — Surrogate Endpoint (SUR): Serum creatinine
Study 39072356 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39072356 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 39073142 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39073142 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 39073523 — Surrogate Endpoint (SUR): Forced vital capacity
Study 39073577 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39073812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39073812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 39074931 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 39074992 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study 39074992 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study 39074992 — Predictive Biomarker (PRD): PRKN mRNA
Genes: PRKN; PARK2
Study 39074992 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study 39074992 — Predictive Biomarker (PRD): PINK1 mRNA
Genes: PINK1
Study 39074992 — Predictive Biomarker (PRD): PARK7 mRNA
Genes: PARK7
Study 39075156 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 39075156 — Surrogate Endpoint (SUR): Forced vital capacity
Study 39075268 — Predictive Biomarker (PRD): PIM2 mRNA
Genes: PIM2
Study 39075531 — Predictive Biomarker (PRD): ITGB1 mRNA
Genes: ITGB1; FNRB; MDF2; MSK12
Study 39075620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39075931 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 39075931 — Predictive Biomarker (PRD): LAIR2 mRNA
Genes: LAIR2; CD306
Study 39075931 — Predictive Biomarker (PRD): MANF mRNA
Genes: MANF; ARMET; ARP
Study 39075931 — Predictive Biomarker (PRD): NELL2 mRNA
Genes: NELL2; NRP2
Study 39075931 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 39075931 — Predictive Biomarker (PRD): EDA2R mRNA
Genes: EDA2R; TNFRSF27; XEDAR; UNQ2448/PRO5727/PRO34080
Study 39075931 — Predictive Biomarker (PRD): KYNU mRNA
Genes: KYNU
Study 39075931 — Predictive Biomarker (PRD): LAYN mRNA
Genes: LAYN; UNQ208/PRO234
Study 39075931 — Predictive Biomarker (PRD): MSR1 mRNA
Genes: MSR1; SCARA1
Study 39075931 — Predictive Biomarker (PRD): SMOC2 mRNA
Genes: SMOC2; SMAP2; MSTP117
Study 39076099 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39076386 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 39076545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39076593 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study 39076700 — Surrogate Endpoint (SUR): Serum potassium
Study 39076700 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 39076944 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 39076951 — Surrogate Endpoint (SUR): Blood pressure
Study 39077002 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 39077002 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39077398 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 39077419 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 39077519 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 39077655 — Surrogate Endpoint (SUR): Blood pressure
Study 39077768 — Safety Biomarker (SAF): Uromodulin
Genes: UMOD
Study 39077886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39079071 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 39079111 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 39079111 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 39079111 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 39079163 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 39079894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39079925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39079925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39079928 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study 39080181 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 39080545 — Surrogate Endpoint (SUR): Forced vital capacity
Study 39081632 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 39081738 — Surrogate Endpoint (SUR): Urinary oxalate
Study 39081746 — Surrogate Endpoint (SUR): Serum creatinine
Study 39081837 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39082399 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 39082421 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 39082675 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study 39082730 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39083105 — Predictive Biomarker (PRD): RIT1 mRNA
Genes: RIT1; RIBB; RIT; ROC1
Study 39083323 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39083340 — Predictive Biomarker (PRD): PIGB mRNA
Genes: PIGB
Study 39083587 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39084177 — Surrogate Endpoint (SUR): Blood pressure
Study 39084707 — Surrogate Endpoint (SUR): Blood pressure
Study 39084827 — Predictive Biomarker (PRD): IDE mRNA
Genes: IDE
Study 39084863 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 39085487 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 39085487 — Predictive Biomarker (PRD): CCDC6 mRNA
Genes: CCDC6; D10S170; TST1
Study 39085889 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 39085889 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 39085951 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 39085951 — Surrogate Endpoint (SUR): Blood pressure
Study 39085979 — Surrogate Endpoint (SUR): Blood pressure
Study 39086130 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 39086673 — Predictive Biomarker (PRD): SLC37A4 mRNA
Genes: SLC37A4; G6PT; G6PT1; PRO0685; TRG19
Study 39086948 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 39086948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39088212 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 39088271 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39088398 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 39088398 — Surrogate Endpoint (SUR): Serum testosterone
Study 39088510 — Surrogate Endpoint (SUR): Bone mineral density
Study 39088766 — Predictive Biomarker (PRD): CDS1 mRNA
Genes: CDS1; CDS
Study 39089004 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39089299 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 39089305 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39089305 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 39089519 — Predictive Biomarker (PRD): MBTPS1 mRNA
Genes: MBTPS1; KIAA0091; S1P; SKI1
Study 39089718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39090323 — Surrogate Endpoint (SUR): Blood pressure
Study 39091122 — Surrogate Endpoint (SUR): Blood pressure
Study 39091606 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 39091669 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 39091669 — Surrogate Endpoint (SUR): Blood pressure
Study 39091669 — Surrogate Endpoint (SUR): Serum creatinine
Study 39091672 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 39093262 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39093380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39093380 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39093981 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 39093981 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 39093981 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): IL21 mRNA
Genes: IL21
Study 39093981 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39093981 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 39093981 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39094630 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 39094677 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39094677 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39094734 — Predictive Biomarker (PRD): SMARCA2 mRNA
Genes: SMARCA2; BAF190B; BRM; SNF2A; SNF2L2
Study 39094734 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 39094734 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 39094734 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 39094743 — Monitoring Biomarker (MOI): HBV DNA
Study 39095759 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 39095808 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 39095866 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 39096895 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study 39096929 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 39097313 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 39097328 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 39097413 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 39097413 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 39097413 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 39097467 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 39097549 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 39097739 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study 39098432 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39098432 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 39098454 — Predictive Biomarker (PRD): Hormone receptor
Study 39098454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39098454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39099093 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39101114 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 39101472 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 39101506 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39102712 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39102712 — Predictive Biomarker (PRD): CCR9 mRNA
Genes: CCR9; GPR28
Study 39102756 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 39103472 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39103508 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 39103901 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 39105067 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 39105067 — Surrogate Endpoint (SUR): Serum creatinine
Study 39105193 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 39105373 — Predictive Biomarker (PRD): PMM2 mRNA
Genes: PMM2
Study 39105794 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 39105794 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39105794 — Predictive Biomarker (PRD): H3-3A mRNA
Genes: H3-3A; H3.3A; H3F3; H3F3A; PP781;; H3-3B; H3.3B; H3F3B
Study 39105794 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39105794 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 39105849 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 39105849 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 39106857 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 39107131 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 39107131 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39107270 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 39107847 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 39107847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39108617 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study 39109192 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39109797 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 39110318 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 39110454 — Surrogate Endpoint (SUR): Serum creatinine
Study 39110471 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 39110531 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 39111209 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 39111551 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39111551 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 39112515 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 39112615 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study 39112628 — Surrogate Endpoint (SUR): Bone mineral density
Study 39112634 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39112634 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5